Clinical trial

A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699

NCT03953092

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-01

PhasePHASE1

Study timeline

Study start (actual)2019-05-01Date precision: day

Registry last updated2021-01-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabete Mellitusunresolved

Interventions

YG1699DRUG

PlacebosDRUG

Sponsors & collaborators

Youngene Therapeutics Inc., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03953092 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.